Connection
 
																	
																		 Sarah Johnson to Risk Factors  
																	
																		
																	 
																	
																		This is a "connection" page, showing publications Sarah Johnson has written about Risk Factors.    
																	
																		
																	 
																	
																			
																					
	
						
				
		
			
			
			| 
				
				
			 | 
			
				
				
					|   | 
					Connection Strength  | 
					  | 
				 
				
					  | 
					   | 
					  | 
				 
				
					|   | 
					0.084  | 
					  | 
				 
				 
			 | 
			
				
				
			 | 
			 
			 
		 
	 	
	
	
		
		
			- 
				Wattier RL, Bucayu RFT, Boge CLK, Ross RK, Yildirim I, Zaoutis TE, Palazzi DL, Vora SB, Castagnola E, Avil?s-Robles M, Danziger-Isakov L, Tribble AC, Sharma TS, Arrieta AC, Maron G, Berman DM, Yin DE, Sung L, Green M, Roilides E, Belani K, Romero J, Soler-Palacin P, L?pez-Medina E, Nolt D, Bin Hussain IZ, Muller WJ, Hauger SB, Halasa N, Dulek D, Pong A, Gonzalez BE, Abzug MJ, Carlesse F, Huppler AR, Rajan S, Aftandilian C, Ardura MI, Chakrabarti A, Hanisch B, Salvatore CM, Klingspor L, Knackstedt ED, Lutsar I, Santolaya ME, Shuster S, Johnson SK, Steinbach WJ, Fisher BT. Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal Network. J Pediatric Infect Dis Soc. 2023 Sep 27; 12(9):487-495.	
				
				
					Score: 0.029
				 
			 
		
			- 
				Boyle EM, Rosenthal A, Wang Y, Farmer P, Rutherford M, Ashby C, Bauer M, Johnson SK, Wardell CP, Hoering A, Schinke C, Thanendrarajan S, Zangari M, Barlogie B, Davies FE, Walker BA, van Rhee F, Morgan GJ. High-risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse. Br J Haematol. 2021 10; 195(2):283-286.	
				
				
					Score: 0.025
				 
			 
		
			- 
				Mehdi SJ, Johnson SK, Epstein J, Zangari M, Qu P, Hoering A, van Rhee F, Schinke C, Thanendrarajan S, Barlogie B, Davies FE, Morgan GJ, Yaccoby S. Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes. Br J Haematol. 2019 02; 184(4):578-593.	
				
				
					Score: 0.020
				 
			 
		
			- 
				Xiong W, Wu X, Starnes S, Johnson SK, Haessler J, Wang S, Chen L, Barlogie B, Shaughnessy JD, Zhan F. An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood. 2008 Nov 15; 112(10):4235-46.	
				
				
					Score: 0.010
				 
			 
		
		 
	 
																				
                                                                            
																		
																	 
																 
															 | 
		
																
																	
																		
																			
																					              Connection Strength             
  The connection strength for concepts is the sum of the scores for each matching publication.
  Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author. 
																				
																		
																	 
																 
															 |